CytoDyn Inc. (CYDY): R&D Expense
Older than the company's other figures. The latest R&D Expense is for the year ended 2024-05-31, while the company's latest annual report covers the year ended 2026-05-31. Its later filings do not report this line under the concept TickerFacts maps.
$7.24M
Year ended 2024-05-31
-48.6%
3-year compound annual growth
-29.8%
5-year compound annual growth
+6.2%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-05-31 | $7.24M | +175.1% | 2024-08-15, From 2023-06-01 |
| 2023-05-31 | $2.63M | -90.3% | 2024-08-15, From 2022-06-01 |
| 2022-05-31 | $27.04M | -49.4% | 2023-09-14, From 2021-06-01 |
| 2021-05-31 | $53.40M | +1.4% | 2022-08-15, From 2020-06-01 |
| 2020-05-31 | $52.64M | +23.9% | 2022-08-15, From 2019-06-01 |
| 2019-05-31 | $42.49M | +11.2% | 2021-07-30, From 2018-06-01 |
| 2018-05-31 | $38.22M | +89.2% | 2020-08-14, From 2017-06-01 |
| 2017-05-31 | $20.21M | +47.1% | 2019-08-14, From 2016-06-01 |
| 2016-05-31 | $13.73M | -9.4% | 2018-07-27, From 2015-06-01 |
| 2015-05-31 | $15.16M | +280.7% | 2016-07-19, From 2014-06-01 |
| 2014-05-31 | $3.98M | +542.3% | 2015-07-10, From 2013-06-01 |
| 2013-05-31 | $619.8K | +16.9% | 2014-07-10, From 2012-06-01 |
| 2012-05-31 | $530.0K | +10.2% | 2013-08-29, From 2011-06-01 |
| 2011-05-31 | $480.8K | n/a | 2012-08-22, From 2010-06-01 |